Myeloperoxidase (MPO) is involved in reactive oxygen species-induced tissue damage and the production of dysfunctional HDL [206,207], and can promote oxidative stress, inflammation, and endothelial dysfunction leading to the progression of chronic kidney disease [208]. This evidence concerns the gene MPO and chronic kidney disease.